Approvals/CIMA-AEMPS/ENTYVIO 300 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

ENTYVIO 300 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Takeda Pharma A/S🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 6fe79de592b7a862
Drug Cima Aemps Name: ENTYVIO 300 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 14923001IP
Holder Company Name: Takeda Pharma A/S
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/takeda-pharma-a-s
Authorization Date: 2020-10-01
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 300 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Takeda Pharma A/S
Company Detail Path: /organization/takeda-pharma-a-s

VEDOLIZUMAB

300 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 1, 2020

Approval ID

6fe79de592b7a862

Type

Standard